SNI Global stays abreast of new topics of interest and importance to soy while also adding to the scientific literature. In FY23, SNI Global finalized and published the soy and skin health clinical trial. In addition, we oversaw the continuation of two other ongoing clinical research studies-- one finished clinical intervention in December and is now in the analysis phase; and one finished recruitment this month.
SNI Global translates the scientific evidence to soy stakeholders, health professionals and researchers across the globe through key messages, videos, branded partnerships, blog posts, fact sheets, social media content, monthly e-newsletters, webinars, and at in-person conferences. Communicating with this impactful audience amplifies soy health and nutrition science through trusted and influential voices.
SNI Global members and soy stakeholders participated in our bi-annual meetings and contributed scientific and communications activities to leverage U.S. soy checkoff funds. The organization’s global footprint continues to grow. FY23 was the inaugural year for the Scientific Advisory Committees which provide a platform for soy stakeholders throughout Asia, Africa, and Latin America to share opportunities and threats for soy worldwide.